Who We Are

Global Health


Our Global Health Division seeks innovative, ambitious, and scalable solutions to address health problems that have a major impact in developing countries. Learn more about the advisory committee.

Trevor Mundel

Global Health

Trevor Mundel leads the foundation’s efforts to develop high-impact interventions against the leading causes of death and disability in developing countries.

Emilio Emini

HIV and Tuberculosis

Emilio A. Emini, Ph.D. leads the team focused on accelerating the reduction in the incidence of HIV infection, in high-burden geographies/populations of Southern and Eastern Africa.

Robert S. Hart

Disease Modeling

Robert S. Hart leads the team that builds innovative data analysis tools to facilitate eradication of infectious disease by the global health community.

Dan Hartman

Integrated Development

Dr. Dan Hartman, director, Integrated Development, leads a team that provides technical expertise in drug and diagnostic development.

Toni Hoover

Strategy, Planning and Management

Dr. Toni Hoover leads a team that supports the programs and functions with business strategy and operations, portfolio and project management, and engagement with industry and product development partners.

Rasa Izadnegahdar

Maternal, Newborn & Child Health Discovery & Tools

Dr. Rasa Izadnegahdar leads the Maternal, Newborn, Child Health Discovery & Tools portfolio.

Chris Karp

Discovery & Translational Sciences

Chris Karp leads the team whose mission is to catalyze innovation for the discovery and translation of transformative solutions to global health and development inequity.

Keith Klugman


Keith Klugman leads the foundation’s work to reduce child deaths from pneumonia, neonatal sepsis, and meningitis.

Tracia Luh

Program Chief Financial Officer

Tracia Luh leads the team that provides financial and strategic planning and analytical support across the foundation's work in global health.

Katey Einterz Owen

Neglected Tropical Diseases

Dr. Katey Einterz Owen has end-to-end responsibility for the investment portfolio in controlling, eliminating, and eradicating the diseases of the London Declaration.

Subhanu Saxena

Innovation Introduction

Subhanu Saxena spearheads key cross-functional initiatives for the foundation and is building capabilities to enhance the foundation’s ability to support introduction of new innovations at scale.

Dan Wattendorf

Innovative Technology Solutions

Dan Wattendorf leads efforts to identify and create biotechnology platforms that result in new options for global health.

Jennifer Weisman

Director and Chief of Staff,
Global Health

Jennifer Weisman serves as an extension of the president, Global Health and drives the prioritization, communication, and execution of Global Health objectives.

Philip Welkhoff


Philip Welkhoff, director, leads the foundation’s strategy to eradicate malaria.

Anita Zaidi

President, Gender Equality and Director, Vaccine Development, Surveillance and EDD

Anita Zaidi oversees the foundation’s efforts to achieve gender equality and is director of the Vaccine Development, Surveillance, and Enteric and Diarrheal Diseases programs.

Scientific Advisory Committee

Our Global Health Program advisory committee comprises a group of esteemed experts from outside of the foundation who offer a wide range of experiences and perspectives. This group plays an important role in strengthening our work by offering independent assessments of our strategies and helping us evaluate results.

Visit Our Blog